English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  The benefits, costs and feasibility of a low incidence COVID-19 strategy

Czypionka, T., Iftekhar, E. N., Prainsack, B., Priesemann, V., Bauer, S., Calero Valdez, A., et al. (2022). The benefits, costs and feasibility of a low incidence COVID-19 strategy. The Lancet Regional Health - Europe, 13: 100294. doi:10.1016/j.lanepe.2021.100294.

Item is

Basic

show hide
Genre: Journal Article

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Czypionka, Thomas, Author
Iftekhar, Emil N.1, Author              
Prainsack, Barbara, Author
Priesemann, Viola1, Author              
Bauer, Simon1, Author              
Calero Valdez, André, Author
Cuschieri, Sarah, Author
Glaab, Enrico, Author
Grill, Eva, Author
Krutzinna, Jenny, Author
Lionis, Christos, Author
Machado, Helena, Author
Martins, Carlos, Author
Pavlakis, George N., Author
Perc, Matjaž, Author
Petelos, Elena, Author
Pickersgill, Martyn, Author
Skupin, Alexander, Author
Schernhammer, Eva, Author
Szczurek, Ewa, Author
Tsiodras, Sotirios, AuthorWilleit, Peter, AuthorWilmes, Paul, Author more..
Affiliations:
1Max Planck Research Group Neural Systems Theory, Max Planck Institute for Dynamics and Self-Organization, Max Planck Society, ou_2616694              

Content

show
hide
Free keywords: -
 Abstract: In the summer of 2021, European governments removed most NPIs after experiencing prolonged second and third waves of the COVID-19 pandemic. Most countries failed to achieve immunization rates high enough to avoid resurgence of the virus. Public health strategies for autumn and winter 2021 have ranged from countries aiming at low incidence by re-introducing NPIs to accepting high incidence levels. However, such high incidence strategies almost certainly lead to the very consequences that they seek to avoid: restrictions that harm people and economies. At high incidence, the important pandemic containment measure ‘test-trace-isolate-support’ becomes inefficient. At that point, the spread of SARS-CoV-2 and its numerous harmful consequences can likely only be controlled through restrictions. We argue that all European countries need to pursue a low incidence strategy in a coordinated manner. Such an endeavour can only be successful if it is built on open communication and trust.

Details

show
hide
Language(s): eng - English
 Dates: 2022
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: DOI: 10.1016/j.lanepe.2021.100294
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: The Lancet Regional Health - Europe
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: 7 Volume / Issue: 13 Sequence Number: 100294 Start / End Page: - Identifier: ISSN: 26667762